Table 2 |
|||||
|
Relationship of a decreased CEACAM1 expression with diabetes, severe obesity, high grade fatty liver and non-alcoholic steatohepatitis |
|||||
|
Total (n = 99) |
Decreased CEACAM1 expression (n = 29) (%) |
p-value |
|||
|
|
|||||
|
Diabetics |
|||||
|
No |
50 |
13 (26) |
0.467 |
||
|
Yes |
49 |
16 (33) |
|||
|
Severe obesity |
|||||
|
No |
59 |
1 (2) |
<0.0009 |
||
|
Yes |
40 |
28 (70) |
|||
|
High grade fatty liver |
|||||
|
No |
64 |
0 (0) |
<0.0009 |
||
|
Yes |
35 |
29 (83) |
|||
|
Non-alcoholic steatohepatitis* |
<0.0009 |
||||
|
No |
17 |
6 (35) |
|||
|
Yes |
23 |
22 (96) |
|||
|
|
|||||
|
* Only 40 severely obese patients was examined for non-alcoholic steatohepatitis |
|||||
|
Lee Diagnostic Pathology 2011 6:40 doi:10.1186/1746-1596-6-40 |
|||||